Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jason Hoppe

Concepts (174)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Emergency Service, Hospital
37
2025
1918
4.360
Why?
Analgesics, Opioid
23
2024
919
4.320
Why?
Buprenorphine
9
2025
162
3.310
Why?
Decision Support Systems, Clinical
7
2025
206
3.280
Why?
Opioid-Related Disorders
12
2025
484
3.140
Why?
Prescription Drug Monitoring Programs
6
2023
14
2.990
Why?
Narcotic Antagonists
10
2025
164
1.930
Why?
Opiate Substitution Treatment
8
2025
136
1.830
Why?
Practice Patterns, Physicians'
14
2023
1257
1.720
Why?
Naloxone
3
2024
112
1.630
Why?
Back Pain
4
2023
53
1.360
Why?
Prescription Drugs
5
2017
109
1.050
Why?
Pain
4
2023
788
1.030
Why?
Electronic Health Records
5
2025
977
0.970
Why?
Emergency Medicine
3
2024
217
0.790
Why?
Drug Overdose
5
2021
326
0.750
Why?
Length of Stay
3
2024
1132
0.660
Why?
Pain Management
3
2017
330
0.550
Why?
Drug Prescriptions
4
2023
242
0.530
Why?
Attitude of Health Personnel
4
2024
1102
0.530
Why?
Drug Monitoring
2
2017
214
0.500
Why?
Physicians
3
2024
872
0.460
Why?
Controlled Substances
1
2014
1
0.460
Why?
Humans
49
2025
129527
0.450
Why?
Substance Abuse Detection
2
2014
79
0.450
Why?
Pharmacies
1
2014
36
0.440
Why?
Adult
24
2025
35505
0.430
Why?
Prescriptions
2
2023
67
0.420
Why?
Drug-Seeking Behavior
1
2013
22
0.420
Why?
Retrospective Studies
16
2024
14532
0.400
Why?
Middle Aged
17
2025
31087
0.380
Why?
Pharmacists
1
2014
247
0.370
Why?
Cannabinoids
3
2020
154
0.370
Why?
Male
27
2025
63586
0.350
Why?
Patient Discharge
1
2016
854
0.330
Why?
Female
25
2025
68650
0.320
Why?
Abdominal Pain
3
2019
142
0.290
Why?
Drug Packaging
2
2017
41
0.270
Why?
Marijuana Abuse
2
2020
233
0.260
Why?
Cross-Sectional Studies
8
2021
5078
0.240
Why?
Academic Medical Centers
2
2017
478
0.220
Why?
Delivery of Health Care
2
2021
896
0.210
Why?
Vomiting
3
2020
129
0.210
Why?
Capsaicin
2
2020
25
0.200
Why?
Benzodiazepines
3
2023
138
0.200
Why?
Prescription Drug Misuse
1
2022
40
0.180
Why?
Substance Withdrawal Syndrome
1
2023
175
0.180
Why?
Quality Indicators, Health Care
1
2023
297
0.180
Why?
Young Adult
8
2019
12438
0.170
Why?
Certification
1
2020
94
0.160
Why?
Patient Handoff
1
2020
32
0.160
Why?
Infection Control
1
2020
143
0.160
Why?
Antiemetics
1
2019
41
0.160
Why?
Haloperidol
1
2019
32
0.160
Why?
Ketorolac
1
2019
20
0.160
Why?
Qualitative Research
2
2024
1231
0.160
Why?
Drug Storage
2
2017
58
0.150
Why?
Poisoning
2
2017
111
0.150
Why?
Social Work
1
2020
83
0.150
Why?
Automobile Driving
1
2020
140
0.150
Why?
Risk Factors
4
2023
9779
0.150
Why?
United States
7
2021
13865
0.150
Why?
Quality Improvement
2
2024
1103
0.140
Why?
Acetaminophen
2
2011
248
0.140
Why?
Referral and Consultation
2
2021
732
0.140
Why?
Accidents, Home
1
2017
29
0.140
Why?
Alcoholism
1
2023
764
0.140
Why?
Medical Staff, Hospital
1
2017
81
0.130
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2019
339
0.130
Why?
Logistic Models
3
2017
1983
0.130
Why?
Marijuana Smoking
1
2019
247
0.120
Why?
Pharmacovigilance
1
2015
21
0.120
Why?
Drug Utilization
2
2014
170
0.120
Why?
Odds Ratio
2
2017
1018
0.120
Why?
Pneumonia, Viral
1
2020
342
0.120
Why?
Inappropriate Prescribing
1
2016
53
0.120
Why?
Coronavirus Infections
1
2020
336
0.120
Why?
Codeine
1
2015
4
0.120
Why?
Pandemics
2
2021
1500
0.120
Why?
Guideline Adherence
2
2017
526
0.120
Why?
Hydrocodone
1
2015
16
0.120
Why?
Adverse Drug Reaction Reporting Systems
1
2015
74
0.120
Why?
Cohort Studies
2
2016
5423
0.120
Why?
Medication Reconciliation
1
2015
29
0.120
Why?
Prospective Studies
3
2023
7150
0.120
Why?
Medication Errors
1
2015
96
0.120
Why?
Oxycodone
1
2015
43
0.120
Why?
Self Report
2
2020
800
0.110
Why?
Aged
8
2020
22063
0.110
Why?
Urban Population
1
2017
442
0.110
Why?
Health Services Accessibility
1
2021
897
0.110
Why?
Indazoles
1
2014
66
0.110
Why?
Antipsychotic Agents
2
2019
180
0.100
Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
244
0.100
Why?
Respiratory Insufficiency
1
2016
312
0.100
Why?
Aged, 80 and over
4
2019
7052
0.100
Why?
Adolescent
6
2019
20409
0.100
Why?
Chronic Pain
1
2016
253
0.100
Why?
Education, Medical, Graduate
1
2016
439
0.100
Why?
Cooperative Behavior
1
2014
432
0.090
Why?
Colorado
3
2019
4403
0.090
Why?
Chemical and Drug Induced Liver Injury, Chronic
1
2011
11
0.090
Why?
Hospitalization
1
2020
2076
0.090
Why?
Fractures, Bone
1
2015
395
0.080
Why?
Curriculum
1
2016
922
0.080
Why?
Analgesics, Non-Narcotic
1
2011
122
0.080
Why?
Acetylcysteine
1
2010
145
0.080
Why?
Practice Guidelines as Topic
1
2017
1510
0.080
Why?
Pharmacy Service, Hospital
1
2009
90
0.070
Why?
Cardiovascular System
1
2009
136
0.070
Why?
Antidotes
1
2009
136
0.070
Why?
Prescription Drug Overuse
2
2017
13
0.070
Why?
Consensus
2
2021
622
0.060
Why?
Nausea
2
2019
111
0.060
Why?
Medical History Taking
2
2015
117
0.060
Why?
Nonprescription Drugs
2
2015
66
0.050
Why?
Phenobarbital
1
2023
19
0.050
Why?
Lorazepam
1
2023
26
0.050
Why?
Interviews as Topic
1
2024
707
0.040
Why?
Case-Control Studies
2
2019
3383
0.040
Why?
Wisconsin
1
2020
99
0.040
Why?
Organizational Innovation
1
2020
137
0.040
Why?
Community Health Workers
1
2020
59
0.040
Why?
Administration, Topical
1
2019
147
0.040
Why?
Data Collection
1
2022
649
0.040
Why?
Syndrome
1
2019
338
0.040
Why?
Risk Assessment
2
2017
3255
0.040
Why?
Betacoronavirus
1
2020
252
0.040
Why?
Continuity of Patient Care
1
2020
276
0.030
Why?
Health Transition
1
2016
7
0.030
Why?
Tertiary Care Centers
1
2017
153
0.030
Why?
Chi-Square Distribution
1
2017
515
0.030
Why?
Surveys and Questionnaires
2
2019
5429
0.030
Why?
Plant Preparations
1
2015
32
0.030
Why?
Focus Groups
1
2017
447
0.030
Why?
Child Behavior
1
2017
235
0.030
Why?
Analgesics
1
2016
194
0.030
Why?
Health Care Surveys
1
2016
557
0.030
Why?
Guidelines as Topic
1
2016
261
0.030
Why?
Hospitals, Teaching
1
2014
113
0.030
Why?
Vitamins
1
2015
173
0.030
Why?
Hospitals, Pediatric
1
2017
514
0.030
Why?
Analysis of Variance
1
2016
1286
0.030
Why?
Multivariate Analysis
1
2016
1491
0.020
Why?
Program Evaluation
1
2016
873
0.020
Why?
Reproducibility of Results
1
2019
3081
0.020
Why?
Eating
1
2014
371
0.020
Why?
Arabia
1
2011
2
0.020
Why?
Dietary Supplements
1
2015
532
0.020
Why?
Disease Outbreaks
1
2014
349
0.020
Why?
Drug Administration Routes
1
2010
37
0.020
Why?
Decision Making
1
2017
860
0.020
Why?
Aging
1
2020
1770
0.020
Why?
Injections, Intravenous
1
2010
202
0.020
Why?
Age Factors
1
2017
3150
0.020
Why?
Quetiapine Fumarate
1
2009
23
0.020
Why?
Dibenzothiazepines
1
2009
17
0.020
Why?
Aripiprazole
1
2009
17
0.020
Why?
Risperidone
1
2009
29
0.020
Why?
Infusions, Intravenous
1
2010
402
0.020
Why?
Anaphylaxis
1
2010
99
0.020
Why?
Thiazoles
1
2009
118
0.020
Why?
Safety
1
2010
335
0.020
Why?
Drug Therapy, Combination
1
2011
1037
0.020
Why?
Quinolones
1
2009
127
0.020
Why?
Child
2
2017
20932
0.020
Why?
Piperazines
1
2009
339
0.020
Why?
Internship and Residency
1
2016
1049
0.020
Why?
Dose-Response Relationship, Drug
1
2011
2013
0.020
Why?
Evidence-Based Medicine
1
2009
715
0.010
Why?
Infant
1
2017
9005
0.010
Why?
Child, Preschool
1
2017
10499
0.010
Why?
Prognosis
1
2011
3772
0.010
Why?
Treatment Outcome
1
2010
10232
0.010
Why?
Hoppe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)